Breast cancer |
Hematogenous and lymphatic spread |
Axillary lymph nodes |
Indicates advanced stage; often associated with poorer prognosis |
[90, 91] |
Melanoma |
Via lymphatics primarily |
Sentinel lymph nodes |
Early detection in sentinel node can improve outcomes |
[92] |
Lung cancer |
Lymphatic spread; direct extension |
Mediastinal and hilar lymph nodes |
Nodal involvement often indicative of advanced disease |
[93] |
Prostate cancer |
Lymphatic and hematogenous routes |
Pelvic lymph nodes |
Correlates with higher grade and stage of cancer |
[94] |
Gastric cancer |
Lymphatic dissemination |
Perigastric lymph nodes |
Predicts poorer survival; guides therapeutic decisions |
[95] |
Head and neck cancer |
Lymphatics, direct extension, sometimes hematogenous |
Cervical lymph nodes |
Critical for staging and prognosis; affects treatment choice |
[96] |
Colorectal cancer |
Primarily through lymphatics |
Regional lymph nodes |
Important for staging and treatment planning |
[97] |
Ovarian cancer |
Transcoelomic spread, lymphatics, hematogenous |
Para-aortic and pelvic lymph nodes |
Advanced stage indicator, influences treatment strategy |
[98] |
Thyroid cancer |
Lymphatic and hematogenous spread |
Cervical and mediastinal lymph nodes |
Indicates more advanced disease; impacts treatment decisions |
[99] |
Bladder cancer |
Primarily lymphatic dissemination |
Pelvic and abdominal lymph nodes |
Nodal metastasis is a marker for advanced stage and poor prognosis |
[100] |
Kidney cancer |
Hematogenous spread and lymphatic pathways |
Regional lymph nodes |
Presence in lymph nodes often indicates metastatic disease |
[101] |
Esophageal cancer |
Lymphatic spread, direct extension |
Mediastinal and cervical lymph nodes |
Critical for staging; impacts survival and treatment options |
[102] |
Pancreatic cancer |
Lymphatic spread, perineural and vascular invasion |
Peripancreatic and retroperitoneal nodes |
Early lymph node involvement associated with worse prognosis |
[103] |
Cervical cancer |
Lymphatic dissemination |
Pelvic and para-aortic lymph nodes |
Important for staging and treatment planning; affects prognosis |
[104] |
Testicular cancer |
Lymphatic and hematogenous routes |
Para-aortic and pelvic lymph nodes |
Indicates stage of disease; important for prognosis and treatment |
[105] |
Endometrial cancer |
Lymphatic spread |
Pelvic and para-aortic lymph nodes |
Influences staging and therapeutic approach; impacts prognosis |
[106] |
Leukemia |
Hematogenous spread, infiltration |
Inguinal, axillary, cervical lymph nodes |
Lymph node involvement can indicate progression and subtype |
[107] |
Hodgkin's lymphoma |
Sequential spread from one lymph node group to next |
Cervical, axillary, mediastinal lymph nodes |
Critical for staging; often has good prognosis if detected early |
[108] |
Non-Hodgkin's lymphoma |
Lymphatic and hematogenous spread |
Cervical, axillary, inguinal lymph nodes |
Staging and subtype classification; significant for prognosis |
[109] |
Bone cancer (e.g., osteosarcoma) |
Hematogenous spread |
Regional lymph nodes, distal sites |
Rare but suggests advanced disease and impacts prognosis |
[110] |
Skin cancer (Non-melanoma) |
Lymphatic spread, direct extension |
Regional lymph nodes |
Lymph node metastasis is rare but indicates advanced disease |
[111] |
Soft tissue sarcoma |
Hematogenous and lymphatic spread |
Regional lymph nodes |
Nodal involvement is rare; indicates high grade, advanced disease |
[112] |
Gallbladder cancer |
Lymphatic and direct spread |
Pericholedochal and cystic duct lymph nodes |
Indicates advanced disease; poor prognostic factor |
[113] |
Nasopharyngeal carcinoma |
Lymphatic spread |
Cervical lymph nodes |
Early involvement common; important for staging and prognosis |
[114] |